Should thrombolytic therapy be the first-line treatment for acute ischemic stroke? Thrombolysis--not a panacea for ischemic stroke.
about
Dehydroascorbic acid, a blood-brain barrier transportable form of vitamin C, mediates potent cerebroprotection in experimental strokeCurrent perspectives on the use of intravenous recombinant tissue plasminogen activator (tPA) for treatment of acute ischemic strokeEndovascular thrombectomy following acute ischemic stroke: a single-center case series and critical review of the literature.Endovascular approaches to acute stroke, part 1: Drugs, devices, and data.Emergency physician treatment of acute stroke with recombinant tissue plasminogen activator: a retrospective analysis.Safety of tPA in stroke mimics and neuroimaging-negative cerebral ischemia.Update on intravenous tissue plasminogen activator for acute stroke: from clinical trials to clinical practice.Thrombolysis in ischemic strokes with no arterial occlusionThrombolysis in acute ischaemic stroke.Candidates for thrombolytic treatment in acute ischaemic stroke--where are our patients in Hong Kong?Efficacy of intravenous thrombolysis according to stroke subtypes: the Madrid Stroke Network data.Diffusion- and perfusion-weighted imaging in acute lacunar infarction: is there a mismatch?The probability of middle cerebral artery MRA flow signal abnormality with quantified CT ischaemic change: targets for future therapeutic studies.Third international stroke trial (IST-3) of thrombolysis for acute ischaemic strokeWhy don't more patients receive intravenous rt-PA for acute stroke?Intravenous rt-PA: a tenth anniversary reflectionSystemic thrombolytic therapy of acute ischemic stroke with rtPA.Endovascular treatment strategies for acute ischemic stroke.Treatment of acute ischemic stroke: systemic or local?Intravenous thrombolysis in patients with stroke attributable to small artery occlusion.Should all stroke patients receive tissue plasminogen activator therapy, despite mild or improving symptoms?When less is more (brain)-Comment on "Rivaroxaban plasma levels in acute ischemic stroke and intracerebral hemorrhage".Does thrombolysis benefit patients with lacunar syndrome?
P2860
Q24555180-229B3539-4858-406A-9536-D91D24BD869BQ30414441-868D9505-8D81-4F40-8BDA-875400734559Q30436396-F02E2AEA-C077-4007-A6C7-2B1B69A07FCDQ33417215-2E6BA891-8B18-412C-98D2-795E8D8DD52FQ33674195-1AABDD16-4BCA-4EFF-BD85-AC438F2F0825Q33874850-A4CDE348-56EC-46EC-8B57-12C2E0B56972Q33956289-5C7B4FEE-3777-4783-B9BD-11A3B878A050Q34143581-34617175-537E-4605-8644-FB408C0A3E40Q34164541-74C68E8A-F578-4290-9361-5EBC76782A26Q34293439-B1560374-D172-4AD4-B833-3AA8F7870235Q34320218-7D5681B3-3410-4EC1-8474-6C26C3B31F51Q35018869-8B1C8B51-7BD8-4C12-BD6D-B97F4296E71BQ35476867-889865BB-2D93-427E-A3E2-AEC622719EBBQ36742130-6D9809BE-EDE8-4116-8A1A-327A873FBE33Q36794959-2B6F0FAE-8656-4D06-8F96-F5AF698B35C8Q36982822-8E7403DA-E2E2-4F3A-94E1-896E53E7F24AQ37610275-FC49F174-C5D9-4D3D-A9A0-41005DC33529Q37960110-9F1C6082-FC26-4E6E-BFFD-CB5ABA7EBCE8Q40063905-B7CB8528-2E8E-4057-9A03-6DA0A9CC1B7BQ43171508-3ED99B32-CA34-4E8D-BDAA-97A5157BC250Q46422762-65C4E853-2622-44B8-A27D-BFE62F08068EQ47823288-C8259D7F-06A7-4BDA-B083-B3548546FB7FQ48619439-C2CDCA4E-9D57-4C43-92D5-FE45C922F878
P2860
Should thrombolytic therapy be the first-line treatment for acute ischemic stroke? Thrombolysis--not a panacea for ischemic stroke.
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年学术文章
@wuu
1997年学术文章
@zh
1997年学术文章
@zh-cn
1997年学术文章
@zh-hans
1997年学术文章
@zh-my
1997年学术文章
@zh-sg
1997年學術文章
@yue
1997年學術文章
@zh-hant
name
Should thrombolytic therapy be ...... a panacea for ischemic stroke.
@en
Should thrombolytic therapy be ...... a panacea for ischemic stroke.
@nl
type
label
Should thrombolytic therapy be ...... a panacea for ischemic stroke.
@en
Should thrombolytic therapy be ...... a panacea for ischemic stroke.
@nl
prefLabel
Should thrombolytic therapy be ...... a panacea for ischemic stroke.
@en
Should thrombolytic therapy be ...... a panacea for ischemic stroke.
@nl
P2093
P1476
Should thrombolytic therapy be ...... a panacea for ischemic stroke.
@en
P2093
P304
1309-10; discussion 1313
P356
10.1056/NEJM199710303371812
P407
P577
1997-10-01T00:00:00Z